GC Medical Science Corp
142280
Company Profile
Business description
GC Medical Science Corp is engaged in the manufacturing of medical supplies and related other medications. The company has developed and distributed a variety of sophisticated reagents to medical institutions in Korea and international markets around the world, including the U.S., Russia, Europe, Africa, Middle East, and India. Its reagents include infectious diseases (HIV, HBV, HCV etc.) test reagents, and tumor marker and parasitological test reagents.
Contact
107, Ihyeon-ro 30beon-gil
Giheung-gu
Gyeonggi-do
Bojeong-dong
Yongin-si16924
KORT: +82 802979000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
134
Stocks News & Analysis
stocks
Why stocks sometimes fall for no obvious reason
How the private markets impact all equity investors.
stocks
Poor organic growth obscured by acquisition for ASX listed share
Sales dropped by 2% without impact of acquisition.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,892.60 | 0.40 | 0.00% |
| CAC 40 | 8,086.00 | 31.42 | -0.39% |
| DAX 40 | 24,606.77 | 130.47 | -0.53% |
| Dow JONES (US) | 50,285.66 | 276.31 | 0.55% |
| FTSE 100 | 10,443.47 | 11.13 | 0.11% |
| HKSE | 25,519.22 | 132.70 | 0.52% |
| NASDAQ | 26,293.10 | 22.74 | 0.09% |
| Nikkei 225 | 63,094.61 | 1,410.47 | 2.29% |
| NZX 50 Index | 12,908.19 | 30.12 | 0.23% |
| S&P 500 | 7,445.72 | 12.75 | 0.17% |
| S&P/ASX 200 | 8,670.30 | 1.80 | -0.02% |
| SSE Composite Index | 4,082.96 | 5.68 | 0.14% |